Skip to main content
Top
Published in: Abdominal Radiology 10/2023

Open Access 10-07-2023 | Hepatocellular Carcinoma | Hepatobiliary

Dynamic contrast-enhanced CT and clinical features of sarcomatoid hepatocellular carcinoma

Authors: Guangming He, Weiqing Huang, Zhimei Zhou, Hui Wu, Qin Tian, Lilian Tan, Xi Li

Published in: Abdominal Radiology | Issue 10/2023

Login to get access

Abstract

Purpose

To investigate the dynamic contrast-enhanced computed tomography (CECT) features and clinical characteristics of sarcomatoid hepatocellular carcinoma (S-HCC).

Methods

We retrospectively reviewed the CECT data and clinical findings of 13 patients (11 male and 2 female, with an average age of 58.6 ± 11.2 years) with pathologically proven S-HCC, including 9 patients with surgical resection and 4 patients with biopsy examination. All patients underwent CECT scans. Two radiologists reviewed and evaluated general features, CECT features and extratumoral features of each lesions based on a consensus.

Results

Among the thirteen tumors, a mean size of 66.7 mm was observed, ranging in diameter from 30 to 146 mm. Seven of thirteen patients had hepatitis B virus (HBV) infection and an elevation of alpha-fetoprotein (AFP) level. Most of cases located in the right lobe of liver (84.6%, 11/13). Nine of thirteen tumors showed lobulated or wavy contours and infiltrative morphology, while eight tumors presented with unclear margin. The tumor textures were mainly heterogeneous for ischemia or necrosis, with solid components dominantly in all cases. Eight of thirteen tumors exhibited “slow-in and and slow-out” dynamic enhancement pattern in CECT, with a enhancement peak in the portal venous phase. Portal vein or hepatic thrombus, adjacent organs invasion and lymph node metastasis were observed in two patients, respectively. Four of thirteen lesions occurred intrahepatic metastasis and hepatic surface retraction respectively.

Conclusion

S-HCC gengerally seen in elderly male with HBV infection and elevated AFP level. The CT manifestations including: large diameter, frequently hepatic right lobe involvement, lobular or wavy contours, ill-defined margins, infiltrative morphology, obvious heterogeneity and dynamic enhancement pattern of “slow-in and and slow-out” , contributed to the diagnosis of S-HCC. These tumors usually occurred hepatic surface retraction and intrahepatic metastasis.
Literature
1.
go back to reference Hamilton SR, Aaltonen LA (2000) Pathology and genetics of tumours of the digestive system. Lyon: IARC press. Hamilton SR, Aaltonen LA (2000) Pathology and genetics of tumours of the digestive system. Lyon: IARC press.
2.
go back to reference Morisue R, Kojima M, Suzuki T, et al. Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses. International journal of cancer, 2021,149(3):546–560.CrossRefPubMed Morisue R, Kojima M, Suzuki T, et al. Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses. International journal of cancer, 2021,149(3):546–560.CrossRefPubMed
3.
go back to reference Kojiro M, Sugihara S, Kakizoe S, et al. Hepatocellular carcinoma with sarcomatous change: a special reference to the relationship with anticancer therapy. Cancer chemotherapy and pharmacology, 1989,23 Suppl(S1):S4–S8. Kojiro M, Sugihara S, Kakizoe S, et al. Hepatocellular carcinoma with sarcomatous change: a special reference to the relationship with anticancer therapy. Cancer chemotherapy and pharmacology, 1989,23 Suppl(S1):S4–S8.
4.
go back to reference Kakizoe S, Kojiro M, Nakashima T. Hepatocellular carcinoma with sarcomatous change. Clinicopathologic and immunohistochemical studies of 14 autopsy cases. Cancer, 1987,59(2):310–316. Kakizoe S, Kojiro M, Nakashima T. Hepatocellular carcinoma with sarcomatous change. Clinicopathologic and immunohistochemical studies of 14 autopsy cases. Cancer, 1987,59(2):310–316.
5.
go back to reference Liao S, Su T, Jeng Y, et al. Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma. Hepatology, 2019,69(1):209–221.CrossRefPubMed Liao S, Su T, Jeng Y, et al. Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma. Hepatology, 2019,69(1):209–221.CrossRefPubMed
6.
7.
go back to reference Koo H R, Park M, Kim M, et al. Radiological and clinical features of sarcomatoid hepatocellular carcinoma in 11 cases. Journal of computer assisted tomography, 2008,32(5):745–749.CrossRefPubMed Koo H R, Park M, Kim M, et al. Radiological and clinical features of sarcomatoid hepatocellular carcinoma in 11 cases. Journal of computer assisted tomography, 2008,32(5):745–749.CrossRefPubMed
8.
go back to reference Wu L, Tsilimigras D I, Farooq A, et al. Management and outcomes among patients with sarcomatoid hepatocellular carcinoma: A population-based analysis . Cancer, 2019,125(21):3767–3775.CrossRefPubMed Wu L, Tsilimigras D I, Farooq A, et al. Management and outcomes among patients with sarcomatoid hepatocellular carcinoma: A population-based analysis . Cancer, 2019,125(21):3767–3775.CrossRefPubMed
9.
go back to reference Marijon H, Dokmak S, Paradis V, et al. Epithelial-to-mesenchymal transition and acquired resistance to sunitinib in a patient with hepatocellular carcinoma . Journal of hepatology, 2011,54(5):1073–1078.CrossRefPubMed Marijon H, Dokmak S, Paradis V, et al. Epithelial-to-mesenchymal transition and acquired resistance to sunitinib in a patient with hepatocellular carcinoma . Journal of hepatology, 2011,54(5):1073–1078.CrossRefPubMed
10.
go back to reference Obara K, Matsumoto N, Okamoto M, et al. Insufficient radiofrequency ablation therapy may induce further malignant transformation of hepatocellular carcinoma . Hepatol Int, 2008,2(1):116–123.CrossRefPubMedPubMedCentral Obara K, Matsumoto N, Okamoto M, et al. Insufficient radiofrequency ablation therapy may induce further malignant transformation of hepatocellular carcinoma . Hepatol Int, 2008,2(1):116–123.CrossRefPubMedPubMedCentral
12.
go back to reference Gu K, Kim Y K, Min J H, et al. Imaging features of hepatic sarcomatous carcinoma on computed tomography and gadoxetic acid-enhanced magnetic resonance imaging . Abdominal imaging, 2017,42(5):1424–1433.CrossRef Gu K, Kim Y K, Min J H, et al. Imaging features of hepatic sarcomatous carcinoma on computed tomography and gadoxetic acid-enhanced magnetic resonance imaging . Abdominal imaging, 2017,42(5):1424–1433.CrossRef
14.
go back to reference Maeda T, Adachi E, Kajiyama K, et al. Spindle cell hepatocellular carcinoma. A clinicopathologic and immunohistochemical analysis of 15 cases . Cancer, 1996,77(1):51–57. Maeda T, Adachi E, Kajiyama K, et al. Spindle cell hepatocellular carcinoma. A clinicopathologic and immunohistochemical analysis of 15 cases . Cancer, 1996,77(1):51–57.
15.
go back to reference Wang Q B, Cui B K, Weng J M, et al. Clinicopathological characteristics and outcome of primary sarcomatoid carcinoma and carcinosarcoma of the liver . J Gastrointest Surg, 2012,16(9):1715–1726.CrossRefPubMed Wang Q B, Cui B K, Weng J M, et al. Clinicopathological characteristics and outcome of primary sarcomatoid carcinoma and carcinosarcoma of the liver . J Gastrointest Surg, 2012,16(9):1715–1726.CrossRefPubMed
16.
go back to reference Lu J, Zhang J, Xiong X Z, et al. Primary hepatic sarcomatoid carcinoma: clinical features and prognosis of 28 resected cases . J Cancer Res Clin Oncol, 2014,140(6):1027–1035.CrossRefPubMed Lu J, Zhang J, Xiong X Z, et al. Primary hepatic sarcomatoid carcinoma: clinical features and prognosis of 28 resected cases . J Cancer Res Clin Oncol, 2014,140(6):1027–1035.CrossRefPubMed
17.
go back to reference Lv T R, Hu H J, Regmi P, et al. Sarcomatoid hepatocellular carcinoma versus conventional hepatocellular carcinoma: a systematic review and meta-analysis . J Cancer Res Clin Oncol, 2022,148(7):1685–1696.CrossRefPubMed Lv T R, Hu H J, Regmi P, et al. Sarcomatoid hepatocellular carcinoma versus conventional hepatocellular carcinoma: a systematic review and meta-analysis . J Cancer Res Clin Oncol, 2022,148(7):1685–1696.CrossRefPubMed
18.
go back to reference Wang J P, Yao Z G, Sun Y W, et al. Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma . World J Gastroenterol, 2020,26(29):4327–4342.CrossRefPubMedPubMedCentral Wang J P, Yao Z G, Sun Y W, et al. Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma . World J Gastroenterol, 2020,26(29):4327–4342.CrossRefPubMedPubMedCentral
19.
go back to reference Li Z, Wu X, Bi X, et al. Clinicopathological features and surgical outcomes of four rare subtypes of primary liver carcinoma . Chin J Cancer Res, 2018,30(3):364–372.CrossRefPubMedPubMedCentral Li Z, Wu X, Bi X, et al. Clinicopathological features and surgical outcomes of four rare subtypes of primary liver carcinoma . Chin J Cancer Res, 2018,30(3):364–372.CrossRefPubMedPubMedCentral
20.
go back to reference Yoon J K, Choi J, Rhee H, et al. MRI features of histologic subtypes of hepatocellular carcinoma: correlation with histologic, genetic, and molecular biologic classification . European radiology, 2022. Yoon J K, Choi J, Rhee H, et al. MRI features of histologic subtypes of hepatocellular carcinoma: correlation with histologic, genetic, and molecular biologic classification . European radiology, 2022.
21.
go back to reference Chen L, Ruan S, Wang P, et al. Imaging features of primary hepatic sarcomatoid carcinoma: Differentiation from hepatocellular carcinoma and intrahepatic cholangiocarcinoma on CT: A preliminary study . Heliyon, 2023,9(3):e14123.CrossRefPubMedPubMedCentral Chen L, Ruan S, Wang P, et al. Imaging features of primary hepatic sarcomatoid carcinoma: Differentiation from hepatocellular carcinoma and intrahepatic cholangiocarcinoma on CT: A preliminary study . Heliyon, 2023,9(3):e14123.CrossRefPubMedPubMedCentral
22.
go back to reference Zhang H, Chai S, Chen L, et al. MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma . Frontiers in oncology, 2021,11:611738.CrossRefPubMedPubMedCentral Zhang H, Chai S, Chen L, et al. MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma . Frontiers in oncology, 2021,11:611738.CrossRefPubMedPubMedCentral
23.
go back to reference Seo N, Kim M J, Rhee H. Hepatic sarcomatoid carcinoma: magnetic resonance imaging evaluation by using the liver imaging reporting and data system . Eur Radiol, 2019,29(7):3761–3771.CrossRefPubMed Seo N, Kim M J, Rhee H. Hepatic sarcomatoid carcinoma: magnetic resonance imaging evaluation by using the liver imaging reporting and data system . Eur Radiol, 2019,29(7):3761–3771.CrossRefPubMed
24.
go back to reference Bello H R, Mahdi Z K, Lui S K, et al. Hepatocellular Carcinoma With Atypical Imaging Features: Review of the Morphologic Hepatocellular Carcinoma Subtypes With Radiology-Pathology Correlation . J Magn Reson Imaging, 2022,55(3):681–697.CrossRefPubMed Bello H R, Mahdi Z K, Lui S K, et al. Hepatocellular Carcinoma With Atypical Imaging Features: Review of the Morphologic Hepatocellular Carcinoma Subtypes With Radiology-Pathology Correlation . J Magn Reson Imaging, 2022,55(3):681–697.CrossRefPubMed
25.
go back to reference Katabathina V S, Khanna L, Surabhi V R, et al. Morphomolecular Classification Update on Hepatocellular Adenoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma . Radiographics, 2022,42(5):1338–1357.CrossRefPubMed Katabathina V S, Khanna L, Surabhi V R, et al. Morphomolecular Classification Update on Hepatocellular Adenoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma . Radiographics, 2022,42(5):1338–1357.CrossRefPubMed
26.
go back to reference Shi D, Sun J, Ma L, et al. Clinical and imaging characteristics of primary hepatic sarcomatoid carcinoma and sarcoma: a comparative study . BMC cancer, 2020,20(1):977.CrossRefPubMedPubMedCentral Shi D, Sun J, Ma L, et al. Clinical and imaging characteristics of primary hepatic sarcomatoid carcinoma and sarcoma: a comparative study . BMC cancer, 2020,20(1):977.CrossRefPubMedPubMedCentral
27.
go back to reference Calderaro J, Ziol M, Paradis V, et al. Molecular and histological correlations in liver cancer . Journal of hepatology, 2019,71(3):616–630.CrossRefPubMed Calderaro J, Ziol M, Paradis V, et al. Molecular and histological correlations in liver cancer . Journal of hepatology, 2019,71(3):616–630.CrossRefPubMed
28.
go back to reference Enane F O, Saunthararajah Y, Korc M. Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells . Cell Death Dis, 2018,9(9):912.CrossRefPubMedPubMedCentral Enane F O, Saunthararajah Y, Korc M. Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells . Cell Death Dis, 2018,9(9):912.CrossRefPubMedPubMedCentral
29.
go back to reference Li Q, Li B, Dong C, et al. 20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription . Eur J Pharmacol, 2017,815:173–180.CrossRefPubMed Li Q, Li B, Dong C, et al. 20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription . Eur J Pharmacol, 2017,815:173–180.CrossRefPubMed
Metadata
Title
Dynamic contrast-enhanced CT and clinical features of sarcomatoid hepatocellular carcinoma
Authors
Guangming He
Weiqing Huang
Zhimei Zhou
Hui Wu
Qin Tian
Lilian Tan
Xi Li
Publication date
10-07-2023
Publisher
Springer US
Published in
Abdominal Radiology / Issue 10/2023
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-023-03983-1

Other articles of this Issue 10/2023

Abdominal Radiology 10/2023 Go to the issue

Classics in Abdominal Radiology

The split-wall sign

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.